Applications published 31 January 2007
Methods for treating blood disorders with nitric oxide donor compounds
Nitromed 1746882*
Stabilised hyaluronin preparations and related methods
SK Pharmaceuticals 1746884*
Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
University of West Virginia Patent Foundation 1746885*
Compounds, compsns and methods for treatment of hepatitis C viral infections and associated diseases
Viropharma 1746888*
Delayed release formulations of 6-mercaptopurine
Teva Pharmaceutical Industries 1746975*
Liposomes useful for drug delivery
Hermes Biosciences 1746976*
Active drug delivery in the gastrointestinal tract
E-Pill Pharma 1746977*
Scored pharmaceutical tablets comprising a plurality of segments
Accu-Break Pharmaceuticals 1746979*
Pharmaceutical dosage form comprising pellets as well as its manufacturing process
Altana Pharma 1746980*
Medicinal aerosol formulation products with improved chemical stability
Cheisi Farmaceutici 1746981*
Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis and cardiovascular diseases
Universita" degli studi di Milano 1746982*
Use of ghrelin antagonists for improving cognition and memory
Novo Nordisk 1746983*
Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity
Hofman, Robert F 1746984*
Method for augmenting the effects of serotonin reuptake inhibitors
Duke University 1746985*
Active substance combination combining a carbinol combined with at least an NSAID
Laboratoires del Dr Esteve 1746986*
DNA pkinase inhibitors for treating cancer and diabetes
Novartis Forschungsstiftung 1746987*
Spiroderivatives for the treatment of hypertension
Darley Pharmaceuticals 1746988*
Methods of using and compsns comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
Celgene 1746989*
Use of mast cells inhibitors for treating patients exposed to chemical or biological weapons
AB Science 1746990*
DAAO inhibiting benzisoxazoles for treating mental disorders
Janssen Pharmaceutica 1746991*
Use of N-substituted imino sugars for appetite suppression
United Therapeutics 1746992*
Controlled release metformin compsns
Andrx Labs 1746993*
Thienopyridinone compounds and methods of treatment
Epix Delaware 1746994*
Method of using and compsns comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
Celgene 1746995*
Compsn for progeny gender control
AQ+ 1746996*
3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamines as modulators of chemokine receptors
Incyte 1746997*
Combination therapy for lower urinary tract symptoms
Ranbaxy Laboratories 1746998*
4-phenylamino-quinazolin-6-yl-amides
Warner-Lambert 1746999*
Ethanol extraction of phytosterols from corn fibre
Archer-Daniels-Midland 1747000*
Management of breakthrough bleeding in extended hormonal contraceptive regimens
Schering 1747001*
Phospholipase inhibitors localised in the gastrointestinal lumen
Ilypsa 1747003*
Pharmaceutical compsns for metabolic insufficiencies
Blass, John 1747004*
Geldamamycin compounds and methods of use
Kosan Biosciences 1747005*
Compsns comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug
Panacea Biotec 1747006*
Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation
AnaMar Medical 1747007*
Crude extracts from andrographis paniculata
Hutchison Medipharma Enterprises 1747008*
Use of histones for the early diagnosis and/or preventive therapy of virus-infected living cells and a biochip for carrying out said diagnosis
Symbiotec Gesellschaft zur Erforschung und Entwicklung auf dem Gebiete der Biotechnologie 1747009*
Use of sulglicotide for the treatment of mucositis
Gentium 1747010*
Means and method for diagnosis, prophylaxis and therapy of connective tissue diseases
Sigrist, Gerold; Lorenz, Wolfgang 1747011*
Preparation of salmonella broad-spectrum vaccines
Creatogen Laboratoires 1747012*
Lipid-extracted therapeutic vaccine and method of use
Ngu, Victor Anomah 1747013*
Modulation of lysophosphatidyl-choline and treatment of diet-induced conditions
Ilypsa 1747014*
Solution phase biopanning method using engineered decoy proteins
Centocor 1747015*
Use of dipyridamole for treatment of resistance to platelet inhibitors
Boehringer Ingelheim International 1747016*
Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
Hofmann, Robert 1747017*
Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy
Leibnitz-Institut fuer Festkoerper- und Werkstoffforschung Dresden; Technische Universitaet Dresden; Hamstein Consult 1747018*
Camptothecin derivatives conjugated in position 20 with integrin antagonists
Sigma-Tau Industrie Farmaceutiche Riunite; Istituto Nazionale per lo Studio e la Cura dei Tumori 1747019*
7-T-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
Sigma-Tau Industrie Farmaceutiche Riunite; Istituto Nazionale per lo Studio e la Cura dei Tumori 1747020*
Self-immolative linkers and drug conjugates
Medarex 1747021*
Inhibition of hairless protein mRNA
The Trustees of Columbia University in the City of New York 1747022*
Methods and compsns for reducing viral genome amounts in a target cell
The Board of Trustees of the Leland Stanford Junior University 1747023*
DNA virus micro-RNA and methods for inhibiting same
The Rockefeller University 1747024*
Method for diagnosing infectious diseases
The University of Tennessee Research Foundation; Speer, CA; Eda Shigetoshi 1747025*
Biomolecular contrast agents for therapy control in radiation therapy with proton or ion beams
Siemens 1747026*